Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
D000925:Anticoagulants; D000990:Antithrombin III / Q000494:pharmacology; D002807:Chondroitin / Q000031:analogs & derivatives*; D003871:Dermatan Sulfate / Q000494:pharmacology*; D005165:Factor V / Q000037:antagonists & inhibitors; D005170:Factor X / Q000037:antagonists & inhibitors; D015951:Factor Xa; D005343:Fibrinolytic Agents; D006023:Glycoproteins / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology*; D015844:Heparin Cofactor II; D009844:Oligosaccharides / Q000494:pharmacology; D013917:Thrombin / Q000037:antagonists & inhibitors; D013925:Thromboplastin / Q000494:pharmacology
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006023:Glycoproteins; D009844:Oligosaccharides; C022475:prothrombinase complex; D003871:Dermatan Sulfate; D015844:Heparin Cofactor II; D000990:Antithrombin III; D005165:Factor V; D005170:Factor X; D006493:Heparin; D002807:Chondroitin; D013925:Thromboplastin; D013917:Thrombin; D015951:Factor Xa